Xiaofeng Yao Selected Research

citreoviridin

5/2022	Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload.
9/2019	Citreoviridin induces myocardial apoptosis through PPAR-γ-mTORC2-mediated autophagic pathway and the protective effect of thiamine and selenium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaofeng Yao Research Topics

Disease

10	Insulin Resistance 06/2022 - 01/2016
8	Type 2 Diabetes Mellitus (MODY) 02/2022 - 04/2016
6	Inflammation (Inflammations) 07/2022 - 01/2008
6	Squamous Cell Carcinoma of Head and Neck 07/2022 - 01/2017
5	Neoplasms (Cancer) 01/2021 - 01/2009
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 06/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2022 - 03/2020
3	Non-alcoholic Fatty Liver Disease 02/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 06/2013
2	Carcinogenesis 07/2022 - 01/2019
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 12/2021 - 01/2019
2	Glucose Intolerance 11/2020 - 01/2019
2	Fibrosis (Cirrhosis) 03/2020 - 02/2019
2	Diabetes Mellitus 01/2019 - 02/2016
2	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 01/2016
2	Atherosclerosis 08/2017 - 08/2016
1	Acute Kidney Injury (Acute Renal Failure) 05/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022
1	Chronic Renal Insufficiency 01/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022
1	Colitis 12/2021
1	Obesity 05/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2020
1	Hypertension (High Blood Pressure) 03/2020
1	Idiopathic Noncirrhotic Portal Hypertension 03/2020
1	Keshan disease 09/2019
1	Beriberi 09/2019
1	Cardiomyopathies (Cardiomyopathy) 09/2019
1	Cardiotoxicity 09/2019
1	Cerebral Infarction 05/2018
1	Dyslipidemias (Dyslipidemia) 08/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2017
1	Lymphatic Metastasis 01/2017
1	Heart Diseases (Heart Disease) 08/2016

Drug/Important Bio-Agent (IBA)

15	ArsenicIBA 02/2022 - 02/2016
6	InflammasomesIBA 02/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2009
3	CalciumIBA 06/2022 - 01/2022
3	serum P-component (CIt)IBA 05/2022 - 08/2017
3	3-methyladenineIBA 01/2021 - 05/2018
3	Arsenic Trioxide (Trisenox)FDA Link 02/2019 - 01/2018
3	Taurine FDA Link 01/2019 - 01/2018
2	undecan-2-oneIBA 07/2022 - 05/2021
2	Persistent Organic PollutantsIBA 06/2022 - 01/2016
2	perfluorooctaneIBA 06/2022 - 01/2016
2	PatulinIBA 05/2022 - 05/2018
2	MycotoxinsIBA 05/2022 - 09/2019
2	citreoviridinIBA 05/2022 - 09/2019
2	Adenosine Triphosphate (ATP)IBA 05/2022 - 09/2019
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2009
2	LipidsIBA 12/2021 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 05/2021 - 05/2018
2	CollagenIBA 01/2021 - 03/2020
2	Deubiquitinating EnzymesIBA 01/2021 - 01/2021
2	acetopyrrothine (thiolutin)IBA 01/2021 - 01/2021
2	Insulin (Novolin)FDA Link 11/2020 - 01/2019
2	Tacrine (Cognex)FDA Link 01/2019 - 06/2013
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2017
2	CateninsIBA 01/2017 - 01/2017
1	rat MIRN27 microRNAIBA 07/2022
1	MicroRNAs (MicroRNA)IBA 07/2022
1	TubulinIBA 06/2022
1	6-methyladenineIBA 02/2022
1	MethyltransferasesIBA 02/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	theanineIBA 12/2021
1	Diethylhexyl Phthalate (DEHP)IBA 12/2021
1	honokiolIBA 05/2021
1	Cathepsin BIBA 01/2021
1	MicronutrientsIBA 09/2019
1	chromium hexavalent ionIBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 05/2018
1	SB 203580IBA 05/2018
1	Antisense RNA (Anti-Sense RNA)IBA 01/2018
1	WP1066IBA 01/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	PlatinumIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	CholesterolIBA 08/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2017
1	Triglycerides (Triacylglycerol)IBA 08/2017
1	HDL CholesterolIBA 08/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	epidermal growth factor receptor VIIIIBA 01/2017
1	gingerolIBA 08/2016
1	Insulin-Like PeptidesIBA 02/2016
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2017